The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study

Standard chemotherapy for soft tissue sarcomas has shown limited efficacy. Here, we sought to evaluate whether β-adrenergic receptor (β-AR) signalling contributed to the progression of sarcomas and therapy resistance. To assess the translational potential of β-adrenergic receptors, we performed immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Porcelli, Letizia, Garofoli, Marianna, Di Fonte, Roberta, Fucci, Livia, Volpicella, Mariateresa, Strippoli, Sabino, Guida, Michele, Azzariti, Amalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320177/
https://www.ncbi.nlm.nih.gov/pubmed/32591592
http://dx.doi.org/10.1038/s41598-020-67342-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320177/
https://www.ncbi.nlm.nih.gov/pubmed/32591592
http://dx.doi.org/10.1038/s41598-020-67342-6

Ejemplares similares